Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.

NCT00502671 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00502671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00502671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
March 31, 2012
Enrollment
228 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer